PROVEN RESULTS WITH GEMTESA

Significant improvement in overactive bladder symptom relief at 12 weeks

Here are clinical study results seen at 12 weeks that you should know:

People taking GEMTESA® had 2 fewer daily leakage episodes compared with about 1 fewer episode for those taking placebo.

People taking GEMTESA had 2 fewer daily leakage episodes compared with about 1 (-1.4) fewer episode for those taking placebo.*

People taking GEMTESA® had nearly 2 fewer bathroom visits per day compared with about 1 fewer visit per day for those taking placebo.

People taking GEMTESA had nearly 2 (-1.8) fewer bathroom visits per day compared with about 1 (-1.3) fewer visit per day for those taking placebo.

People taking GEMTESA® had nearly 3 fewer bathroom visits with "urge to go" feelings compared with 2 fewer visits for those taking placebo.

People taking GEMTESA had nearly 3 (2.7) fewer bathroom visits with ”urge to go“ feelings compared with 2 fewer visits for those taking placebo.

Additional clinical study results seen at 12 weeks:

About half of people treated with GEMTESA® saw a 75% or greater reduction in daily leakage episodes vs 37% for people taking placebo.

About half (52%) of people taking GEMTESA saw a 75% or greater reduction in daily leakage episodes vs 37% for people taking placebo.*

*403 people received GEMTESA and 405 people received placebo.

526 people received GEMTESA and 520 people received placebo.

You may pay as little as $10 for GEMTESA
with the Simple Savings Program!

SIMPLE SAVINGS

Restrictions and maximum savings limits apply. Coverage and out-of-pocket costs may vary.
Offer not valid for patients participating in Medicare, Medicaid, or other government healthcare programs. See Program Terms, Conditions, and Eligibility Criteria.

Patient ready to save on GEMTESA® with the Simple Savings Program.